(Q44558806)

4 December 2017

title

The combination of yondelis and cisplatin is synergistic against human tumor xenografts (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

D Meco

0 references

T Colombo

1 reference

4 December 2017

P Ubezio

1 reference

4 December 2017

I Nicoletti

1 reference

4 December 2017

E Erba

1 reference

4 December 2017

L Ferrarese

1 reference

4 December 2017

C Sessa

1 reference

4 December 2017

E Cavallini

1 reference

4 December 2017

J Jimeno

1 reference

4 December 2017

G T Faircloth

1 reference

4 December 2017

publication date

1 September 2003

1 reference

European Journal of Cancer

4 December 2017

published in

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

1920-1926

1 reference

Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Unique features of the mode of action of ET-743.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

The expected effect of a combination of agents: the general solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Antitumor activity of taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

Cis-diamminedichloroplatinum (II). A new anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900490-8

7 January 2021

10.1016/S0959-8049(03)00490-8

Identifiers

DOI

1 reference

4 December 2017

1 reference